LAG-3 antagonists by cancer treatment: a patent review
2019
ABSTRACTIntroduction: LAG-3 is checkpoint inhibitor in cancer that coordinates the downregulation of the proliferation of antigen-specific lymphocytes. There is a great need to discover and develop...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
32
References
14
Citations
NaN
KQI